Report Detail

Request for Sample of this report

Other Global Antibody Development Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4507544
    • |
  • 04 February, 2023
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Antibody Development Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Antibody Development Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibody Development Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antibody Development Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antibody Development Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antibody Development Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Development Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Development Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, R&D Systems, Leinco Technologies, Rockland Immunochemicals, Inc. (Rockland) and Bio-Rad, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antibody Development Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibody Development
Polyclonal Antibody Development
Market segment by Application
Medical Industry
Biological Industry
Others
Market segment by players, this report covers
Thermo Fisher Scientific
R&D Systems
Leinco Technologies
Rockland Immunochemicals, Inc. (Rockland)
Bio-Rad
BioGenes
ProteoGenix
Labcorp
Inotiv, Inc.
ProMab Biotechnologies
Kemp Proteins
Synaptic Systems
ARVYS Proteins, Inc.
BBI Solutions
Innovagen AB
BIOTEM
Medimab
OriGene
Abeomics Inc.
RayBiotech
Genscript Biotech Corporation
Sino Biological
Abzena Ltd
Creative Biolabs
Abcam
Antibodies Incorporated
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Development Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Development Services, with revenue, gross margin and global market share of Antibody Development Services from 2018 to 2023.
Chapter 3, the Antibody Development Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibody Development Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Development Services.
Chapter 13, to describe Antibody Development Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Antibody Development Services
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Antibody Development Services by Type
    • 1.3.1 Overview: Global Antibody Development Services Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Antibody Development Services Consumption Value Market Share by Type in 2022
    • 1.3.3 Monoclonal Antibody Development
    • 1.3.4 Polyclonal Antibody Development
  • 1.4 Global Antibody Development Services Market by Application
    • 1.4.1 Overview: Global Antibody Development Services Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Medical Industry
    • 1.4.3 Biological Industry
    • 1.4.4 Others
  • 1.5 Global Antibody Development Services Market Size & Forecast
  • 1.6 Global Antibody Development Services Market Size and Forecast by Region
    • 1.6.1 Global Antibody Development Services Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Antibody Development Services Market Size by Region, (2018-2029)
    • 1.6.3 North America Antibody Development Services Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Antibody Development Services Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Antibody Development Services Market Size and Prospect (2018-2029)
    • 1.6.6 South America Antibody Development Services Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Antibody Development Services Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Antibody Development Services Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 R&D Systems
    • 2.2.1 R&D Systems Details
    • 2.2.2 R&D Systems Major Business
    • 2.2.3 R&D Systems Antibody Development Services Product and Solutions
    • 2.2.4 R&D Systems Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 R&D Systems Recent Developments and Future Plans
  • 2.3 Leinco Technologies
    • 2.3.1 Leinco Technologies Details
    • 2.3.2 Leinco Technologies Major Business
    • 2.3.3 Leinco Technologies Antibody Development Services Product and Solutions
    • 2.3.4 Leinco Technologies Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Leinco Technologies Recent Developments and Future Plans
  • 2.4 Rockland Immunochemicals, Inc. (Rockland)
    • 2.4.1 Rockland Immunochemicals, Inc. (Rockland) Details
    • 2.4.2 Rockland Immunochemicals, Inc. (Rockland) Major Business
    • 2.4.3 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Product and Solutions
    • 2.4.4 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Rockland Immunochemicals, Inc. (Rockland) Recent Developments and Future Plans
  • 2.5 Bio-Rad
    • 2.5.1 Bio-Rad Details
    • 2.5.2 Bio-Rad Major Business
    • 2.5.3 Bio-Rad Antibody Development Services Product and Solutions
    • 2.5.4 Bio-Rad Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Bio-Rad Recent Developments and Future Plans
  • 2.6 BioGenes
    • 2.6.1 BioGenes Details
    • 2.6.2 BioGenes Major Business
    • 2.6.3 BioGenes Antibody Development Services Product and Solutions
    • 2.6.4 BioGenes Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 BioGenes Recent Developments and Future Plans
  • 2.7 ProteoGenix
    • 2.7.1 ProteoGenix Details
    • 2.7.2 ProteoGenix Major Business
    • 2.7.3 ProteoGenix Antibody Development Services Product and Solutions
    • 2.7.4 ProteoGenix Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 ProteoGenix Recent Developments and Future Plans
  • 2.8 Labcorp
    • 2.8.1 Labcorp Details
    • 2.8.2 Labcorp Major Business
    • 2.8.3 Labcorp Antibody Development Services Product and Solutions
    • 2.8.4 Labcorp Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Labcorp Recent Developments and Future Plans
  • 2.9 Inotiv, Inc.
    • 2.9.1 Inotiv, Inc. Details
    • 2.9.2 Inotiv, Inc. Major Business
    • 2.9.3 Inotiv, Inc. Antibody Development Services Product and Solutions
    • 2.9.4 Inotiv, Inc. Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Inotiv, Inc. Recent Developments and Future Plans
  • 2.10 ProMab Biotechnologies
    • 2.10.1 ProMab Biotechnologies Details
    • 2.10.2 ProMab Biotechnologies Major Business
    • 2.10.3 ProMab Biotechnologies Antibody Development Services Product and Solutions
    • 2.10.4 ProMab Biotechnologies Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 ProMab Biotechnologies Recent Developments and Future Plans
  • 2.11 Kemp Proteins
    • 2.11.1 Kemp Proteins Details
    • 2.11.2 Kemp Proteins Major Business
    • 2.11.3 Kemp Proteins Antibody Development Services Product and Solutions
    • 2.11.4 Kemp Proteins Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Kemp Proteins Recent Developments and Future Plans
  • 2.12 Synaptic Systems
    • 2.12.1 Synaptic Systems Details
    • 2.12.2 Synaptic Systems Major Business
    • 2.12.3 Synaptic Systems Antibody Development Services Product and Solutions
    • 2.12.4 Synaptic Systems Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Synaptic Systems Recent Developments and Future Plans
  • 2.13 ARVYS Proteins, Inc.
    • 2.13.1 ARVYS Proteins, Inc. Details
    • 2.13.2 ARVYS Proteins, Inc. Major Business
    • 2.13.3 ARVYS Proteins, Inc. Antibody Development Services Product and Solutions
    • 2.13.4 ARVYS Proteins, Inc. Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 ARVYS Proteins, Inc. Recent Developments and Future Plans
  • 2.14 BBI Solutions
    • 2.14.1 BBI Solutions Details
    • 2.14.2 BBI Solutions Major Business
    • 2.14.3 BBI Solutions Antibody Development Services Product and Solutions
    • 2.14.4 BBI Solutions Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 BBI Solutions Recent Developments and Future Plans
  • 2.15 Innovagen AB
    • 2.15.1 Innovagen AB Details
    • 2.15.2 Innovagen AB Major Business
    • 2.15.3 Innovagen AB Antibody Development Services Product and Solutions
    • 2.15.4 Innovagen AB Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Innovagen AB Recent Developments and Future Plans
  • 2.16 BIOTEM
    • 2.16.1 BIOTEM Details
    • 2.16.2 BIOTEM Major Business
    • 2.16.3 BIOTEM Antibody Development Services Product and Solutions
    • 2.16.4 BIOTEM Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 BIOTEM Recent Developments and Future Plans
  • 2.17 Medimab
    • 2.17.1 Medimab Details
    • 2.17.2 Medimab Major Business
    • 2.17.3 Medimab Antibody Development Services Product and Solutions
    • 2.17.4 Medimab Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Medimab Recent Developments and Future Plans
  • 2.18 OriGene
    • 2.18.1 OriGene Details
    • 2.18.2 OriGene Major Business
    • 2.18.3 OriGene Antibody Development Services Product and Solutions
    • 2.18.4 OriGene Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 OriGene Recent Developments and Future Plans
  • 2.19 Abeomics Inc.
    • 2.19.1 Abeomics Inc. Details
    • 2.19.2 Abeomics Inc. Major Business
    • 2.19.3 Abeomics Inc. Antibody Development Services Product and Solutions
    • 2.19.4 Abeomics Inc. Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Abeomics Inc. Recent Developments and Future Plans
  • 2.20 RayBiotech
    • 2.20.1 RayBiotech Details
    • 2.20.2 RayBiotech Major Business
    • 2.20.3 RayBiotech Antibody Development Services Product and Solutions
    • 2.20.4 RayBiotech Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 RayBiotech Recent Developments and Future Plans
  • 2.21 Genscript Biotech Corporation
    • 2.21.1 Genscript Biotech Corporation Details
    • 2.21.2 Genscript Biotech Corporation Major Business
    • 2.21.3 Genscript Biotech Corporation Antibody Development Services Product and Solutions
    • 2.21.4 Genscript Biotech Corporation Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 Genscript Biotech Corporation Recent Developments and Future Plans
  • 2.22 Sino Biological
    • 2.22.1 Sino Biological Details
    • 2.22.2 Sino Biological Major Business
    • 2.22.3 Sino Biological Antibody Development Services Product and Solutions
    • 2.22.4 Sino Biological Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.22.5 Sino Biological Recent Developments and Future Plans
  • 2.23 Abzena Ltd
    • 2.23.1 Abzena Ltd Details
    • 2.23.2 Abzena Ltd Major Business
    • 2.23.3 Abzena Ltd Antibody Development Services Product and Solutions
    • 2.23.4 Abzena Ltd Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.23.5 Abzena Ltd Recent Developments and Future Plans
  • 2.24 Creative Biolabs
    • 2.24.1 Creative Biolabs Details
    • 2.24.2 Creative Biolabs Major Business
    • 2.24.3 Creative Biolabs Antibody Development Services Product and Solutions
    • 2.24.4 Creative Biolabs Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.24.5 Creative Biolabs Recent Developments and Future Plans
  • 2.25 Abcam
    • 2.25.1 Abcam Details
    • 2.25.2 Abcam Major Business
    • 2.25.3 Abcam Antibody Development Services Product and Solutions
    • 2.25.4 Abcam Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.25.5 Abcam Recent Developments and Future Plans
  • 2.26 Antibodies Incorporated
    • 2.26.1 Antibodies Incorporated Details
    • 2.26.2 Antibodies Incorporated Major Business
    • 2.26.3 Antibodies Incorporated Antibody Development Services Product and Solutions
    • 2.26.4 Antibodies Incorporated Antibody Development Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.26.5 Antibodies Incorporated Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Antibody Development Services Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Antibody Development Services by Company Revenue
    • 3.2.2 Top 3 Antibody Development Services Players Market Share in 2022
    • 3.2.3 Top 6 Antibody Development Services Players Market Share in 2022
  • 3.3 Antibody Development Services Market: Overall Company Footprint Analysis
    • 3.3.1 Antibody Development Services Market: Region Footprint
    • 3.3.2 Antibody Development Services Market: Company Product Type Footprint
    • 3.3.3 Antibody Development Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Antibody Development Services Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Antibody Development Services Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Antibody Development Services Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Antibody Development Services Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Antibody Development Services Consumption Value by Type (2018-2029)
  • 6.2 North America Antibody Development Services Consumption Value by Application (2018-2029)
  • 6.3 North America Antibody Development Services Market Size by Country
    • 6.3.1 North America Antibody Development Services Consumption Value by Country (2018-2029)
    • 6.3.2 United States Antibody Development Services Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Antibody Development Services Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Antibody Development Services Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Antibody Development Services Consumption Value by Type (2018-2029)
  • 7.2 Europe Antibody Development Services Consumption Value by Application (2018-2029)
  • 7.3 Europe Antibody Development Services Market Size by Country
    • 7.3.1 Europe Antibody Development Services Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Antibody Development Services Market Size and Forecast (2018-2029)
    • 7.3.3 France Antibody Development Services Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Antibody Development Services Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Antibody Development Services Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Antibody Development Services Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Antibody Development Services Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Antibody Development Services Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Antibody Development Services Market Size by Region
    • 8.3.1 Asia-Pacific Antibody Development Services Consumption Value by Region (2018-2029)
    • 8.3.2 China Antibody Development Services Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Antibody Development Services Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Antibody Development Services Market Size and Forecast (2018-2029)
    • 8.3.5 India Antibody Development Services Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Antibody Development Services Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Antibody Development Services Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Antibody Development Services Consumption Value by Type (2018-2029)
  • 9.2 South America Antibody Development Services Consumption Value by Application (2018-2029)
  • 9.3 South America Antibody Development Services Market Size by Country
    • 9.3.1 South America Antibody Development Services Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Antibody Development Services Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Antibody Development Services Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Antibody Development Services Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Antibody Development Services Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Antibody Development Services Market Size by Country
    • 10.3.1 Middle East & Africa Antibody Development Services Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Antibody Development Services Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Antibody Development Services Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Antibody Development Services Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Antibody Development Services Market Drivers
  • 11.2 Antibody Development Services Market Restraints
  • 11.3 Antibody Development Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Antibody Development Services Industry Chain
  • 12.2 Antibody Development Services Upstream Analysis
  • 12.3 Antibody Development Services Midstream Analysis
  • 12.4 Antibody Development Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Antibody Development Services. Industry analysis & Market Report on Antibody Development Services is a syndicated market report, published as Global Antibody Development Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Antibody Development Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,777.04
    		4,165.56
    		5,554.08
    		3,246.84
    		4,870.26
    		6,493.68
    		535,084.80
    		802,627.20
    		1,070,169.60
    		290,440.80
    		435,661.20
    		580,881.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo